page image

Vitamines bij sclerodermie

Referenties

  1. Maurice PD et al: Isotretinoin in the treatment of systemic sclerosis; Br. J. Dermatol. 121(3):367-374, 1989. PMID: 2803961.
  2. Leyden JJ: Retinoids and acne; J. Am. Acad. Dermatol. 19(1 Pt 2):164-168, 1988. PMID: 2970475.
  3. Rollman O, Vahlquist A: Oral isotretinoin (13-cis-retinoic acid) therapy in severe acne: Drug and vitamin A concentrations in sebum and skin; J. Invest. Dermatol. 86(4):384-389, 1986. PMID: 2943822.
  4. Ikeda T et al: The vitamin A derivative etretinate improves skin sclerosis in patients with systemic sclerosis; J. Dermatol. Sci. 34(1):62-66, 2004. PMID: 14757285.
  5. Matsuoka LY et al: Cutaneous vitamin D3 formation in progressive systemic sclerosis; J. Rheumatol. 18(8):1196-1198, 1991. PMID: 1658323.
  6. Serup J, Hagdrup H: Vitamin D metabolites in generalized scleroderma. Evidence of a normal cutaneous and intestinal supply with vitamin D; Acta Derm. Venereol. 65(4):343-345, 1985. PMID: 2413693.
  7. Humbert PG et al: Localized scleroderma – response to 1,25-dihydroxyvitamin D3; Clin. Exp. Dermatol. 15(5):396-398, 1990. PMID: 2225549.
  8. Boelsma E et al: Effects of calcitriol on fibroblasts derived from skin of scleroderma patients; Dermatology 191(3):226-233, 1995. PMID: 8534941.
  9. Humbert P et al: Treatment of scleroderma with oral 1,25-dihydroxyvitamin D3: evaluation of skin involvement using non-invasive techniques. Results of an open prospective trial; Acta Derm. Venereol. 73(6):449-451, 1993. PMID: 7906461.
  10. Hulshof MM et al: Oral calcitriol as a new therapeutic modality for generalized morphea; Arch. Dermatol. 130(10):1290-1293, 1994. PMID: 7944511.
  11. Elst EF et al: Treatment of linear scleroderma with oral 1,25-dihyroxyvitamin D3 (calcitriol) in seven children; Pediatr. Dermatol. 16(1):53-58, 1999. PMID: 10028002.
  12. Lowe K, Normal A. Vitamin D and psoriasis. Nutr Rev 50:138-142, 1992. PMID: 1630719.
  13. Cunningham BB et al: Topical calcipotriene for morphea/linear scleroderma; J. Am. Acad. Dermatol. 39(2 Pt 1):211-215, 1998. PMID: 9704831.
  14. Herrick AL et al: Dietary intake of micronutrient antioxidants in relation to blood levels in patients with systemic sclerosis; J. Rheumatol. 23(4):650-653, 1996. PMID: 8730121.
  15. Lundberg AC et al: Dietary intake and nutritional status in patients with systemic sclerosis; Ann. Rheum. Dis. 51(10):1143-1148, 1992. PMID: 1332633.
  16. Ayres S et al: Raynaud’s phenomenon, scleroderma and calcinosis cutis: Response to vitamin E; Cutis 11:54-62, 1973.
  17. Ayres S Jr, Mihan R: Is vitamin E involved in the autoimmune mechanism?; Cutis 21(3):321-325, 1978. PMID: 343998.
  18. Cracowski JL et al: Effects of short-term treatment with vitamin E in systemic sclerosis: a double blind, randomized, controlled trial of efficacy based on urinary isoprostane measurement; Free Radic. Biol. Med. 38(1):98-103, 2005. PMID: 15589377.

Terug naar overzicht